人工智能提高了病理学家对非酒精性脂肪性肝炎患者纤维化评分的一致性。 - Suppr

Artificial Intelligence Improves Pathologist Agreement for Fibrosis Scores in Nonalcoholic Steatohepatitis Patients.

作者信息

Soon Gwyneth S T, Liu Feng, Leow Wei-Qiang, Wee Aileen, Wei Lai, Sanyal Arun J

机构信息

Department of Pathology, National University Hospital, Singapore.

Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China.

出版信息

Clin Gastroenterol Hepatol. 2023 Jul;21(7):1940-1942.e3. doi: 10.1016/j.cgh.2022.05.027. Epub 2022 Jun 10.

DOI:10.1016/j.cgh.2022.05.027

PMID:35697267

Abstract

摘要

相似文献

Artificial Intelligence Improves Pathologist Agreement for Fibrosis Scores in Nonalcoholic Steatohepatitis Patients.人工智能提高了病理学家对非酒精性脂肪性肝炎患者纤维化评分的一致性。

Clin Gastroenterol Hepatol. 2023 Jul;21(7):1940-1942.e3. doi: 10.1016/j.cgh.2022.05.027. Epub 2022 Jun 10.

Development of a diagnostic support system for the fibrosis of nonalcoholic fatty liver disease using artificial intelligence and deep learning.利用人工智能和深度学习开发非酒精性脂肪性肝病纤维化诊断支持系统

Kaohsiung J Med Sci. 2024 Aug;40(8):757-765. doi: 10.1002/kjm2.12850. Epub 2024 May 31.

Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD.非酒精性脂肪性肝病肝纤维化的自动量化和结构模式检测。

Ann Diagn Pathol. 2020 Aug;47:151518. doi: 10.1016/j.anndiagpath.2020.151518. Epub 2020 Apr 12.

Clinical Utility of Change in Nonalcoholic Fatty Liver Disease Activity Score and Change in Fibrosis in NAFLD.非酒精性脂肪性肝病活动评分变化和纤维化变化在非酒精性脂肪性肝病中的临床应用

Clin Gastroenterol Hepatol. 2021 Dec;19(12):2673-2674.e3. doi: 10.1016/j.cgh.2020.11.005. Epub 2020 Nov 3.

Letter to the editor: diagnosing fibrosis and cirrhosis in nonalcoholic fatty liver disease using machine learning models.致编辑的信：使用机器学习模型诊断非酒精性脂肪性肝病中的纤维化和肝硬化

Hepatology. 2023 May 1;77(5):E103-E104. doi: 10.1097/HEP.0000000000000209. Epub 2023 Jan 3.

FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage. FibroScan 可识别患有非酒精性脂肪性肝病和心血管损伤的患者。

Clin Gastroenterol Hepatol. 2020 Feb;18(2):517-519. doi: 10.1016/j.cgh.2018.11.011. Epub 2018 Dec 8.

High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease.高通量、基于机器学习的非酒精性脂肪性肝病患者肝活检组织中脂肪变性、炎症、气球样变、纤维化的定量分析。

Clin Gastroenterol Hepatol. 2020 Aug;18(9):2081-2090.e9. doi: 10.1016/j.cgh.2019.12.025. Epub 2019 Dec 27.

Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years.14 年后肝组织学证实非酒精性脂肪肝向非酒精性脂肪性肝炎肝硬化进展。

Intern Med. 2021 May 1;60(9):1397-1401. doi: 10.2169/internalmedicine.6118-20. Epub 2020 Dec 7.

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective.非酒精性脂肪性肝病肝纤维化定量评估的研究进展：组织学视角。

Clin Mol Hepatol. 2021 Jan;27(1):44-57. doi: 10.3350/cmh.2020.0181. Epub 2020 Nov 19.

Glyphosate Excretion is Associated With Steatohepatitis and Advanced Liver Fibrosis in Patients With Fatty Liver Disease.草甘膦排泄与脂肪性肝病患者的肝炎和肝纤维化进展有关。

Clin Gastroenterol Hepatol. 2020 Mar;18(3):741-743. doi: 10.1016/j.cgh.2019.03.045. Epub 2019 Apr 4.

引用本文的文献

Quantitative fibrosis identifies biliary tract involvement and is associated with outcomes in pediatric autoimmune liver disease.定量纤维化可识别胆道受累情况，并与儿童自身免疫性肝病的预后相关。

Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000594. eCollection 2025 Jan 1.

Digital quantitation of bridging fibrosis and septa reveals changes in natural history and treatment not seen with conventional histology.数字量化桥接纤维化和间隔可揭示常规组织学未见的自然史和治疗变化。

Liver Int. 2024 Dec;44(12):3214-3228. doi: 10.1111/liv.16092. Epub 2024 Sep 9.

Envisioning how to advance the MASH field.展望如何推动 MASH 领域的发展。

Nat Rev Gastroenterol Hepatol. 2024 Oct;21(10):726-738. doi: 10.1038/s41575-024-00938-9. Epub 2024 Jun 4.

Deep learning and digital pathology powers prediction of HCC development in steatotic liver disease.深度学习与数字病理学助力预测脂肪性肝病中肝癌的发展。

Hepatology. 2025 Mar 1;81(3):976-989. doi: 10.1097/HEP.0000000000000904. Epub 2024 May 20.

Potential of Using qFibrosis Analysis to Predict Recurrent and Survival Outcome of Patients with Hepatocellular Carcinoma after Hepatic Resection.qFibrosis 分析预测肝癌患者肝切除术后复发和生存结局的潜力。

Oncology. 2024;102(11):924-934. doi: 10.1159/000538456. Epub 2024 Mar 25.

Fibrosis severity scoring on Sirius red histology with multiple-instance deep learning.基于多实例深度学习的天狼星红组织学纤维化严重程度评分

Biol Imaging. 2023 Jul 18;3:e17. doi: 10.1017/S2633903X23000144. eCollection 2023.

Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions.人工智能辅助数字病理学在非酒精性脂肪性肝炎中的应用：现状与未来方向

J Hepatol. 2024 Feb;80(2):335-351. doi: 10.1016/j.jhep.2023.10.015. Epub 2023 Oct 24.

Digital pathology for nonalcoholic steatohepatitis assessment.数字病理学在非酒精性脂肪性肝炎评估中的应用。

Nat Rev Gastroenterol Hepatol. 2024 Jan;21(1):57-69. doi: 10.1038/s41575-023-00843-7. Epub 2023 Oct 3.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Artificial Intelligence Improves Pathologist Agreement for Fibrosis Scores in Nonalcoholic Steatohepatitis Patients.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献